A Study of Cyclase-Associated Plasma Protein 2 as a Novel Biomarker for Detection of Hepato-Cellular carcinoma in HCV Patients
Michael Yousri Shaker;
Abstract
HCC is the third deadliest and fifth most common
cancer worldwide, despite the widespread use of surveillance
programs in at risk populations, more than half of HCC cases
are diagnosed late, and curative therapies such as surgical
resection, radiofrequency ablation (RFA) or TACE are
possible in less than 30% of patients.
It has a lot of risk factors and cofactors. In Egypt the
major risk factor for the development of HCC is cirrhosis of
the liver which occurs due to many causes. The major known
risk factors for HCC can be divided into four categories: viral
(chronic hepatitis B and hepatitis C), toxic (alcohol and
cancer worldwide, despite the widespread use of surveillance
programs in at risk populations, more than half of HCC cases
are diagnosed late, and curative therapies such as surgical
resection, radiofrequency ablation (RFA) or TACE are
possible in less than 30% of patients.
It has a lot of risk factors and cofactors. In Egypt the
major risk factor for the development of HCC is cirrhosis of
the liver which occurs due to many causes. The major known
risk factors for HCC can be divided into four categories: viral
(chronic hepatitis B and hepatitis C), toxic (alcohol and
Other data
| Title | A Study of Cyclase-Associated Plasma Protein 2 as a Novel Biomarker for Detection of Hepato-Cellular carcinoma in HCV Patients | Authors | Michael Yousri Shaker | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.